Another big CRO deal has landed as Thermo Fisher acquires PPD for $17.4B
Consolidation among big CRO players is continuing to churn.
Following a Wednesday afternoon report from the Wall Street Journal saying a deal was close, Thermo Fisher has announced plans to acquire PPD for $17.4 billion. WSJ had reported that the parties could wrap up an agreement as soon as this week. It’s the second CRO M&A deal in as many months, following the Icon-PRA Health Sciences deal in late February.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.